Advanced Medical Solutions Group plc announced that, as the next step in its communicated plan to refresh the Non-Executive Directors on the Board, Liz Shanahan will be appointed as an Independent Non-Executive Director with immediate effect. Liz is a life sciences entrepreneur with extensive experience advising leading global pharmaceutical and healthcare organizations on their communications. She is currently a Non-Executive Director of Inspiration Healthcare Group plc and Celadon Pharmaceuticals plc (previously Summerway Capital plc), both of which are AIM-listed.

Most recently, she was a Non-Executive Director of UDG Healthcare plc, a company that was listed on the London Stock Exchange and a constituent of the FTSE 250 up until its £2.8 billion takeover in August 2021. Until 2014, she was Global Head of Healthcare & Lifesciences at the NYSE-listed management consultancy, FTI Consulting Inc., which in 2007 acquired the communications business Santé Communications, founded by Liz in 1995. Liz is a Trustee of CW+, the charitable arm of Chelsea & Westminster Foundation Trust Hospital in London and a member of the organisation's Innovations Advisory Board.

Alongside her Board appointments she is a business advisor and Executive coach. Liz will immediately join the Audit, Nomination and Remuneration Committees and will be responsible for Workforce Engagement in line with the UK Corporate Governance Code requirements. The composition of each of the Board Committees from 1 August 2022 is therefore confirmed as follows: Audit Committee: Grahame Cook (Chairman), Douglas Le Fort and Liz Shanahan.

Nomination Committee: Peter Allen (Chairman), Grahame Cook, Douglas Le Fort, Chris Meredith and Liz Shanahan. Remuneration Committee: Douglas Le Fort (Chairman), Peter Allen, Grahame Cook and Liz Shanahan.